CFDE Workbench
DataKnowledgeCloudtrainingcoordination
CFDE Workbench

COL P17050-1 GLY 000040 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)
Protein:

NAGAB HUMAN

Protein (Entity type)
Project:

Portal

Project (Entity type)
Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)
Dcc:

GlyGen

DCC (Entity type)
Collection:

human proteoform glycosylation sites unicarbkb.csv

File (Entity type)
Description:Information for protein P17050-1 in the context of file GLY_000040
Creation Time:2026-03-02 19:56:34.000000
Results found

Linked to

 

Label

Description

 

Compound

Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]b-GlcNAc

Compound (Entity type)

A Compound

Compound

CID 91845155

Compound (Entity type)

A Compound

Compound

Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc

Compound (Entity type)

A Compound

Compound

Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc

Compound (Entity type)

A Compound

Compound

CID 91856528

Compound (Entity type)

A Compound

Compound

Man7GlcNAc2-I

Compound (Entity type)

A Compound

Compound

G93284HQ

Compound (Entity type)

type="Saccharide" mass="1931.68758926" permass="2408.21969164" monosaccharides="10" is_motif="False"...

Protein

NAGAB HUMAN

Protein (Entity type)

Alpha-N-acetylgalactosaminidase (precursor)

Compound

G44444MB

Compound (Entity type)

type="Saccharide" mass="2077.74549812" permass="2582.30890064" monosaccharides="11" is_motif="False"...

Post Translational Modification

p17050-1 177asn 177asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

  • Compound

    Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]b-GlcNAc

    Compound (Entity type)

    A Compound

  • Compound

    CID 91845155

    Compound (Entity type)

    A Compound

  • Compound

    Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc

    Compound (Entity type)

    A Compound

  • Compound

    Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)b-GlcNAc

    Compound (Entity type)

    A Compound

  • Compound

    CID 91856528

    Compound (Entity type)

    A Compound

  • Compound

    Man7GlcNAc2-I

    Compound (Entity type)

    A Compound

  • Compound

    G93284HQ

    Compound (Entity type)

    type="Saccharide" mass="1931.68758926" permass="2408.21969164" monosaccharides="10" is_motif="False"...

  • Protein

    NAGAB HUMAN

    Protein (Entity type)

    Alpha-N-acetylgalactosaminidase (precursor)

  • Compound

    G44444MB

    Compound (Entity type)

    type="Saccharide" mass="2077.74549812" permass="2582.30890064" monosaccharides="11" is_motif="False"...

  • Post Translational Modification

    p17050-1 177asn 177asn defined go:0006486 go:0006487

    Post Translational Modification (Entity type)

    A Post Translational Modification

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2026
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2026
    This repository is under review for potential modification in compliance with Administration directives.